Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors

NATerminatedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 5, 2008

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions
Breast Cancer
Interventions
BEHAVIORAL

Questionnaire

Questionnaires about pain and other symptoms, quality of life, and ability to work will be completed.

OTHER

Phone Calls

A telephone system will call every 2 weeks so that you can rate your symptoms and how they interfere with daily activities. Each call will take about 5 minutes.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER